Next Steps for Research Documentation Review Review the product-page documentation, COA details, analytical testing records, lot traceability, and RUO labeling before evaluating this compound for laboratory research
Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications
V., Metowogo, K., & Aklikokou, K
GLP-1 is the target of many synthetic drugs on the market, initially developed in the treatment of type II diabetes, including: Exendin-4 (ELISA Product S-1297 , Rabbit anti-Exendin-4 Product T-4844 ): In the brain, it increases survival of dopamine neurons and decreases apoptosis of nerve cells, improving neuroplasticity
Intestinal Blockage One of the less common but severe complications associated with GLP-1 drugs is intestinal blockage
It can be dangerous if compounders dont do things by the book, experts say